Table 1: Patient information.
Diabetic Subjects Atrophy Prevalence | Non-Diabetic Controls Atrophy Prevalence | ||||||||
C 2(3.9%) |
N 6(11.8%) |
S 43(84.3%) |
p-value | A 2(6.5%) |
C 6(19.4%) |
N 7(22.6%) |
S 16(51.6%) |
p-value | |
Pepsinogen I(µg/l) | 26.65 ± 5.44 | 71.8 ± 9.9 | 125.1 ± 53.9 | 0.04 | 93.5 ± 36.9 | 18.6 ± 10.3 | 97.9 ± 60.0 | 110.5 ± 31.7 | |
Gastrin-17 pmol/l | 7.5 ± 0.0 | 3.9 ± 0.8 | 24.3 ± 19.2 | 0.02 | 0.1 ± 0.0 | 25.7 ± 26.6 | 8.8 ± 10.4 | 3.6 ± 2.5 | 0.01 |
Sex Males Females |
0(0.0%) 2(100%) |
2(33.3%) 4(66.7%) |
14(32.6%) 29(67.4%) |
0.62 | 1(50%) 1(50%) |
2(33.3%) 4(66.7%) |
5(71.4%) 2(28.6%) |
10(62.5%) 6(37.5%) |
0.03 |
Age(Yrs) 19 - 29 30 - 40 41 - 51 52 - 62 63 - 73 74 - 84 |
55.9 ± 9.8 | 40.3 ± 13.8 | 0.62 | ||||||
0(0.0%) 0(0%) 0(0%) 2(100%) 0(0%) 0(0%) |
0(0%) 0(0%) 2(33.3%) 4(66.7%) 0(0%) 0(0%) |
0(0.0%) 6(14.0%) 4(9.3%) 24(55.8%) 6(14.0%) 3(7.0%) |
0.61 | 0(0%) 0(0%) 2(100%) 0(0%) 0(0%) 0(0%) |
2(33.3%) 1(16.7%) 2(33.3%) 0(0%) 1(16.7%) 0(0%) |
2(28.6%) 1(14.3%) 2(28.6%) 1(14.3%) 1(14.3%) 0(0%) |
6(37.5%) 4(25.0%) 3(18.8%) 3(18.8%) 0(0%) 0(0%) |
||
Dyspepsia No Yes |
0 2(100%) |
2(33.3%) 4(66.7%) |
8(18.6%) 35(81.4%) |
0.54 | 1(50%) 1(50%) |
1(20%) 4(80%) |
1(33.3%) 2(66.7%) |
1(8.3%) 11(91.7%) |
0.45 |